Discontinuation report AURO-AMOXICLAV
Report ID | 218221 |
Drug Identification Number | 02471671 |
Brand name | AURO-AMOXICLAV |
Common or Proper name | AURO-AMOXICLAV |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | CLAVULANIC ACID AMOXICILLIN |
Strength(s) | 125MG 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2024-01-09 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2024-02-02 | English | Compare |
v2 | 2024-02-02 | French | Compare |
Showing 1 to 2 of 2